Industrialization of drug discovery : from target selection through lead optimization /
Industrialization of drug discovery : from target selection through lead optimization /
edited by Jeffrey S. Handen.
- Boca Raton ; London : Taylor & Francis, 2005.
- 305 p. : ill. ; 24 cm.
- Drug discovery series .
- Drug discovery series. .
Includes bibliographical references and index.
Chapter 1.Drug discovery in the modern age: how we got here and what does it mean? -- Chapter 2.The regulatory age -- Chapter 3.Industrialization, not automation -- Chapter 4.Compound management -- Chapter 5.High through-put screening -- Chapter 6.Parallel lead optimization -- Chapter 7.Knowledge management -- Chapter 8.Understanding the value of research -- Chapter 9.Collaboration in a virtual and global environment -- Chapter 10.From genome to drug: ethical issues.
In light of statistics and experience showing that drug discovery and development is getting longer, more expensive, and no better in the sense that the clinical attrition and safety-related market withdrawals today are about the same as they were 20 years ago contributors from pharmaceutical companies and some universities explore a new approach t.
9780824723910 (alk. paper) 9780824723910
2004063486
Pharmaceutical industry.
Drug development.
Pharmacology
Pharmaceutical chemistry & technology
Medical research
Drug Industry--organization & administration
RM301.25 / .I53 2005
615.19 HAN
Includes bibliographical references and index.
Chapter 1.Drug discovery in the modern age: how we got here and what does it mean? -- Chapter 2.The regulatory age -- Chapter 3.Industrialization, not automation -- Chapter 4.Compound management -- Chapter 5.High through-put screening -- Chapter 6.Parallel lead optimization -- Chapter 7.Knowledge management -- Chapter 8.Understanding the value of research -- Chapter 9.Collaboration in a virtual and global environment -- Chapter 10.From genome to drug: ethical issues.
In light of statistics and experience showing that drug discovery and development is getting longer, more expensive, and no better in the sense that the clinical attrition and safety-related market withdrawals today are about the same as they were 20 years ago contributors from pharmaceutical companies and some universities explore a new approach t.
9780824723910 (alk. paper) 9780824723910
2004063486
Pharmaceutical industry.
Drug development.
Pharmacology
Pharmaceutical chemistry & technology
Medical research
Drug Industry--organization & administration
RM301.25 / .I53 2005
615.19 HAN